Cancer

  • Missing first screening appt raises breast cancer death risk – study

    Women who miss their first mammogram face a 40 per cent higher risk of dying from breast cancer over 25 years, mainly because cancers are detected later, new research has found. Nearly a third (32 per cent) of women invited to their first breast screening did not attend. These women were also less likely to [...]

  • Round up: funding for world’s first AI-powered IVF lab, and more

    Femtech World explores the latest business and investment developments in the world of women’s health. Funding supports US launch of world’s first AI-powered, automated IVF lab Conceivable Life Sciences has raised US$50m to accelerate the development and commercialisation of the world's first AI-powered automated IVF laboratory. The funding will help to make the therapy more [...]

  • Mammograms may benefit women well into their 80s, study finds

    Women in their 80s who had regular mammograms showed a 74 per cent lower risk of dying from breast cancer compared with those who did not undergo screening in a recent study. The study also found screened women had a 55 per cent lower risk of recurrence, were more likely to be diagnosed at an [...]

  • Wrist cooling could help managing hot flash study finds

    A cooling wristband device was found to reduce severe hot flash episodes by 46 per cent in breast cancer patients, prostate cancer patients and postmenopausal women, new research has shown. The device reduced severe episodes by 41 per cent in breast cancer patients and 50 per cent in prostate cancer patients and postmenopausal women. It [...]

  • UK’s first Pink Duck Race raises thousands for breast cancer

    The UK’s first pink duck race has raised thousands for breast cancer support after 5,000 rubber ducks floated down Cambridge’s River Cam. Each duck represented a £5 donation to Pink Ribbon Foundation, with participants competing for a nine carat rose gold necklace encrusted with 48 diamonds, shaped like a rubber duck. The winning duck was [...]

  • Campaign calls for menopause support in cancer care

    Campaigners are urging menopause support to be included in cancer treatment plans after a survey found 90 per cent of patients were given no guidance. The survey of 1,200 people revealed most had no support for managing menopausal changes triggered by treatment. The research was carried out by Menopause and Cancer, whose founder and CEO [...]

  • HIV research paves way for new ovarian cancer therapies

    HIV research has identified a new target for ovarian cancer by selectively blocking a cleft in the retinoblastoma protein that protects tumour-supporting macrophages. The discovery could make ovarian – and potentially other – cancers more responsive to immunotherapies, treatments that use the body’s immune system to fight disease. Scientists at the Wistar Institute found that [...]

  • Report warns breast cancer could cost UK economy £4.2bn by 2050

    The financial impact of breast cancer on the UK economy is projected to rise by nearly a third to £4.2bn within 25 years, new analysis warns. The disease is expected to cost between £3.2bn and £3.5bn in 2025, covering NHS diagnosis and treatment as well as lost productivity when patients or carers cannot work. A [...]

  • Study reveals a hidden risk after cervical cancer

    Women who have survived cervical cancer face nearly double the risk of developing anal cancer later in life compared with the general population, new research shows. The study analysed data from more than 85,000 women diagnosed with cervical cancer and followed them over two decades to track secondary diagnoses. Researchers at MUSC Hollings Cancer Center [...]

  • Round up: FDA clearance for AI-powered embryo assessment tool

    Femtech World explores the latest developments in the world of technology and women’s health. 30-minute non-invasive test to revolutionise endometriosis detection A new diagnostic tool for endometriosis will now be available in Canada. EndoDiagnosis will be the sole distributor in Canada for the ENDOSURE Tier 1 diagnostic test for the condition, which cuts down the [...]